One shot to lower bad cholesterol? What we know about Verve 102
For people with very high LDL cholesterol, treatment may involve taking medications regularly for years. Researchers are now exploring whether gene editing could offer a different approach. Verve 102 is an experimental treatment being developed to lower LDL cholesterol by targeting the PCSK9 gene in liver cells. It is designed as a one-time intravenous infusion…